This approach is feasible not only for patients with GATA2 deficiency but also in patients with high index of suspicion for a specific Mendelian disorder but without a known pathogenic mutation. The gene discussed is GATA2; the disease is hyperinsulinemic hypoglycemia, familial, 4.